Fluticasone Propionate, Salmeterol Xinafoate Drug Combination

Known as: Fluticasone Propionate, Salmeterol Xinafoate Drug Combination [Chemical/Ingredient], Fluticasone Propionate - Salmeterol, Fluticasone Propionate Salmeterol Xinafoate Combination 
A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2016
01220102016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BACKGROUND In developing countries, there is a need for access to affordable inhaled respiratory medicines. This study tested the… (More)
  • table 1
Is this relevant?
2014
2014
BACKGROUND Comparative effectiveness of the budesonide-formoterol fumarate dihydrate combination (BFC) and the fluticasone… (More)
Is this relevant?
2011
2011
Purpose: To compare, in commercially-insured individuals ≥40 years old, the risk of chronic obstructive pulmonary disease (COPD… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2010
2010
Limited information exists comparing fluticasone propionate/salmeterol combination (FSC) versus montelukast (MON) in patients… (More)
  • figure 1
  • table 2
  • figure 2
  • table 3
  • figure 3
Is this relevant?
2010
2010
PURPOSE To provide information on the efficacy and safety of Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a Metered… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?